CFR vs ZION

CFR presents a dichotomy between exceptional earnings consistency and deteriorating financial health, as evidenced by a weak Piotroski F-Score of 3/9. While the stock trades between its Graham Number ($123.50) and Intrinsic Value ($191.38), the high PEG ratio of 2.38 and a bearish technical trend (10/100) suggest limited immediate upside. Strong ROE (15.31%) and a sustainable dividend payout (39.82%) provide a fundamental floor, but insider selling and poor deterministic health scores warrant a cautious approach. The company remains a stable earner, but current valuation and health metrics indicate a period of stagnation.

ZION presents a stark contrast between deep valuation discounts and deteriorating fundamental health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades significantly below its Graham Number ($83.55) and Intrinsic Value ($189.98), the low health score and bearish insider sentiment suggest underlying operational risks. Strong year-over-year earnings growth of 38.10% provides a bullish catalyst, but this is offset by a high PEG ratio of 4.29 and a very bearish technical trend. The overall outlook is neutral as the valuation margin of safety battles fundamental fragility.